The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Forecasted Market Value Of The Smart Biopsy Devices Market Across 2026–2030?
The smart biopsy devices market has experienced significant growth in recent years. It is projected to expand from $3.01 billion in 2025 to $3.23 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.2%. This historic expansion can be attributed to factors such as rising cancer incidence rates, increased use of minimally invasive diagnostic procedures, the development of advanced imaging infrastructure, growing adoption of core needle biopsy techniques, and improved clinician training in image-guided diagnostics.
The smart biopsy devices market is anticipated to experience substantial growth over the next few years, projected to reach $4.32 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.6%. This expansion during the forecast period is propelled by factors such as the increasing demand for precision oncology diagnostics, rising investments in intelligent surgical technologies, the expansion of robotic-assisted intervention platforms, a growing emphasis on early disease detection, and the increasing integration of AI-driven diagnostic support. Noteworthy trends expected in this period encompass the increasing adoption of image-guided biopsy systems, the rising utilization of robotic-assisted biopsy procedures, growing integration of real-time tissue feedback technologies, the expansion of minimally invasive diagnostic techniques, and an enhanced focus on diagnostic accuracy and patient safety.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12271&type=smp
What Major Growth Drivers Are Shaping The Outlook Of The Smart Biopsy Devices Market?
The increasing number of cancer diagnoses is projected to stimulate the expansion of the smart biopsy devices market in the future. Cancer is a wide range of illnesses that can arise in virtually any organ or tissue when abnormal cells multiply uncontrollably, transgress their usual boundaries, and either metastasize to other organs or infiltrate adjacent body parts. This growing incidence of cancer has heightened the need for precise and targeted tissue samples, which in turn has spurred the creation and advancement of smart biopsy instruments offering enhanced molecular, imaging, and precision capabilities to aid in diagnosis and treatment planning. For instance, in January 2024, the World Health Organization, a Switzerland-based intergovernmental organization, estimated that new cancer cases would surpass 35 million by 2050, indicating a 77% increase from the approximately 20 million cases and 9.7 million deaths recorded in 2022. Thus, the rising occurrences of cancer are fueling the growth of the smart biopsy devices market.
What Segmentation Levels Are Considered In The Smart Biopsy Devices Market?
The smart biopsy devices market covered in this report is segmented –
1) By Product: Needle-Based Biopsy Instruments, Localization Wires
2) By Guidance Technique: Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques
3) By Application: Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Other Applications
4) By End-User: Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers
Subsegments:
1) By Needle-Based Biopsy Instruments: Core Needle Biopsy Devices, Fine Needle Aspiration (FNA) Devices, Vacuum-Assisted Biopsy Devices
2) By Localization Wires: Hook Wire Localization Devices, Radar Localization Devices, Magnetic Localization Devices
What Trends Are Projected To Affect The Smart Biopsy Devices Market?
Prominent companies in the smart biopsy devices market are concentrating on creating advanced solutions, particularly multi-modality breast biopsy markers, to enhance lesion localization, provide long-term site visibility, and boost diagnostic certainty. Multi-modality markers are specialized biopsy site indicators crafted to maintain clear visibility across ultrasound, mammography, and MRI, thereby assisting clinicians in accurately tracking biopsy locations and enabling precise follow-up assessments. For example, in March 2024, Mammotome, a U.S.-based medical technology firm, unveiled LumiMARK, its subsequent generation 510(k)-cleared breast biopsy site marker intended for multi-modality identification. Offered in three distinct 3D shapes—including Tulip™ and Rose™—the marker guarantees consistent visibility across various imaging modalities and delivers improved long-term detectability within both breast tissue and lymph nodes, consequently supporting more accurate diagnosis and continuous clinical decision-making.
Which Leading Firms Are Contributing To The Growth Of The Smart Biopsy Devices Market?
Major companies operating in the smart biopsy devices market are Becton Dickinson and Company, Boston Scientific Corporation, Hologic Inc., Cook Medical Inc., Medtronic Plc, Olympus Corporation, B. Braun Melsungen AG, CONMED Corporation, FUJIFILM Holdings Corporation, Argon Medical Devices Inc., SOMATEX Medical Technologies GmbH, TSK Laboratory Europe B.V., INRAD Inc., Esaote SpA, Planmed Oy, Canon Medical Systems Corporation, Siemens Healthineers, General Electric Company, Intuitive Surgical Inc., Karl Storz SE And Co KG, Stryker Corporation
Read the full smart biopsy devices market report here:
https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report
Which Regions Are Projected To Dominate The Smart Biopsy Devices Market In The Coming Years?
North America was the largest region in the smart biopsy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the smart biopsy devices market report during the forecast period. The regions covered in the smart biopsy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Smart Biopsy Devices Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=12271&type=smp
Browse Through More Reports Similar to the Global Smart Biopsy Devices Market 2026, By The Business Research Company
Biopsy Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report
Biopsy Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report
Patient Monitoring Devices Market 2026
https://www.thebusinessresearchcompany.com/report/patient-monitoring-devices-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model